
Khiron Life Sciences Corp. (OTCQX:KHRNF) (TSXV:KHRN) (Frankfurt: A2JMZC), a global leader in medical cannabis throughout Latin America and Europe, revealed the results of its 2022 annual general and special meeting of shareholders held on June 23, 2022.
Shareholders approved all of the resolutions detailed in the management information circular of the company dated May 17, 2022, namely: